What is the recommended treatment for a urinary tract infection (UTI) caused by Streptococcus agalactiae (Group B Streptococcus, GBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Streptococcus agalactiae (Group B Streptococcus) UTI

For non-pregnant adults with symptomatic GBS UTI, treat with penicillin or ampicillin for 7-10 days, as GBS remains universally susceptible to beta-lactams and these narrow-spectrum agents minimize collateral resistance. 1

First-Line Treatment Options

Penicillin G is the preferred agent due to its narrow spectrum of activity 1:

  • Dosing: 500 mg orally every 6-8 hours for 7-10 days 1
  • GBS demonstrates 100% susceptibility to penicillin with no resistance reported 2, 3

Ampicillin is an acceptable alternative 1, 4:

  • Dosing: 500 mg orally every 8 hours for 7-10 days 1
  • FDA-approved dosing for genitourinary infections: 500 mg four times daily 4
  • Demonstrates >95% susceptibility in clinical studies 2, 5
  • Should be administered at least 30 minutes before or 2 hours after meals for maximal absorption 4

Penicillin-Allergic Patients

For patients with documented penicillin allergy 1:

  • Clindamycin: 300-450 mg orally every 8 hours 1
  • Critical caveat: Susceptibility testing must be performed before use due to increasing resistance patterns 1
  • Alternative options include cephalothin (100% susceptibility) or erythromycin (>95% susceptibility), though resistance to erythromycin is emerging 2, 5

Avoid fluoroquinolones despite their activity, as resistance rates are concerning (12.8% in recent studies, particularly in men and non-pregnant women) 3

Treatment Duration and Monitoring

Duration: 7-10 days is standard for uncomplicated GBS UTI 1:

  • Treatment should continue for a minimum of 48-72 hours after the patient becomes asymptomatic 4
  • For complicated infections or when prostatitis cannot be excluded in men, extend to 14 days 6

Follow-up: Post-treatment urine culture is warranted to ensure eradication, especially in patients with recurrent UTIs 1

Special Considerations for Complicated UTI

If the patient presents with systemic symptoms or complicated UTI 6:

  • Consider initial IV therapy with ampicillin 2 g IV every 4-6 hours, then transition to oral therapy once clinically stable 6
  • Combination therapy with ampicillin plus an aminoglycoside may be appropriate for severe presentations 6
  • Address any underlying urological abnormalities, as GBS UTIs are frequently associated with comorbidities, particularly diabetes mellitus 3

Critical Pitfalls to Avoid

Do not confuse pregnancy guidelines with non-pregnant patient management: The CDC guidelines mandating treatment of all GBS bacteriuria apply specifically to pregnant women to prevent neonatal disease and should not be applied to non-pregnant patients 1. In non-pregnant adults, treat only if symptomatic or if underlying urinary tract abnormalities exist 1.

Identify and treat reservoirs: GBS can colonize the vagina, urethra, and gastrointestinal tract 2. In women with recurrent infections, consider vaginal lavages with 2% chlorhexidine solution in addition to systemic antibiotics 2, 7.

Avoid tetracycline and co-trimoxazole: These agents show high resistance rates (81.6% and 68.9% respectively) and should not be used empirically 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.